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she Spring 2005 issue begins a new format for Operative
Techniques in Thoracic and Cardiovascular Surgery,
amely a point-counterpoint presentation by technical ex-
erts in these areas of a controversial issue of operative man-
gement in each of our three subspecialties: adult cardiac
urgery, pediatric cardiac surgery, and general thoracic sur-
ery. Going forward, we will follow a similar format in each
ssue.
In this issue, we present aortic arch aneurysm manage-
ent, repair of tetralogy of Fallot, and surgical treatment of
denocarcinoma of the esophagus. I think readers will find
hese articles helpful in understanding the surgical options
or these difficult and complicated problems. We would ap-
reciate reader feedback related to this format.
I am indebted to our Associate Editors, Drs Thoralf Sundt,
ichard Jonas, and newly appointed Associate Editor for gen-
ral thoracic surgery, Steven Mentzer, for their imagination
nd timely help.
orrection of
ortic Arch Aneurysms
nterest in the surgical correction of aortic arch aneurysms
as grown in recent years, in large part because of advances in
nesthetic and perfusion techniques that permit regular use
f circulatory arrest for neurologic protection. Increasing re-
orts of large series with low operative mortality and mor-
idity as well as the description of reliably reproducible tech-
iques are encouraging surgeons to take on the correction of
ortic arch pathologic conditions more aggressively. Some
ould even debate the advisability of performing total arch
eplacement at the time of repair of acute dissection, a con-
ersation that likely would not have gone far only a few years
go.
We are fortunate to have contributions to this issue of
perative Techniques in Thoracic and Cardiovascular Surgery
rom two of the leading surgical groups managing aortic arch
athology on a regular basis. Dr Randall Griepp is an undis-
uted pioneer in the management of arch pathology. He and
is associates, Drs. David Spielvogel and Steven Lansman,
ave beautifully described their current technique for perfu-
ion management and anatomic reconstruction during arch
eplacement as practiced at Mt. Sinai Hospital in New York.
heir approach relies on early selective antegrade perfusion.
heir article is characteristically clear and concise with tech- e
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oi:10.1053/j.optechstcvs.2005.03.002ical details and carefully included “pearls.” We are once
gain indebted to Dr Griepp and group for sharing their
houghtful approach.
A contrasting view is provided by Dr Hazim Safi and his
ssociate, Dr Anthony Estrera. Drs Safi and Estrera have been
uite satisfied with retrograde cerebral perfusion as an alter-
ative to antegrade perfusion, although they emphasize the
mportance of performing it appropriately. Their article pro-
ides a lucid description of what they feel are the important
spects of conducting this technique. They also share with us
heir thoughts on the critical components of arch replace-
ent including the elephant trunk procedure.
We hope that readers will find these descriptions useful.
lthough most of us do not deal with arch surgery on a
egular basis, it is likely that we will be required to manage
ortic arch pathology on at least an intermittent basis. We
ope that these lucid descriptions will remain in your library
o be called on when necessary.
epair of Tetralogy of Fallot
e are grateful to Dr JamesMonro from the United Kingdom
nd Dr Edward Bove from Ann Arbor, Michigan, for helping
o highlight the two different approaches to repair of tetral-
gy of Fallot. Dr Monro has clearly illustrated the traditional
ransventricular approach, which allows ventricular septal
efect closure through the same ventriculotomy that is made
or relief of outflow tract obstruction. Dr Bove’s article dem-
nstrates the transatrial approach to ventricular septal defect
losure and relief of outflow tract obstruction. Excellent re-
ults continue to be reported for both these approaches, and
his, no doubt, will continue to be an ongoing topic of con-
roversy for the foreseeable future.
denocarcinoma
f the Esophagus
he optimal treatment strategy for patients with T3N0 ade-
ocarcinoma of the esophagus is controversial. The twomost
ommonly used resectional strategies are transhiatal esopha-
ectomy (THE) and transthoracic esophagectomy (TTE).
inimally invasive esophagectomy, although practiced in se-
ected centers, is not yet in widespread use. Current clinical
taging modalities of computerized tomography, positron
mission tomography, and esophageal ultrasound with fine
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2 L.H. Cohneedle aspiration biopsy provide accurate staging informa-
ion in the majority of patients.
Advocates of a radical en bloc TTE argue that many pa-
ients with clinically staged T3N0 tumors have occult meta-
tatic nodal disease. They also argue, correctly, that a more
adical resection of the primary tumor, surrounding soft tis-
ue, and regional lymph nodes can be accomplished by TTE.
his approach may confer a survival advantage over the less
adical THE. Unfortunately, no compelling comparative data
xist to support this contention.
Those favoring the THE approach argue correctly that this
rocedure is associated with lesser morbidity than TTE.
In experienced centers, operative mortality for esophagec-omy should be well under 5%, yet complications occur in
pproximately 50% of patients. These procedures are techni-
ally challenging, and successful outcome depends on pre-
ise adherence to details of operative technique. Drs Altorki
nd Orringer are not only proponents of TTE and THE, re-
pectively, but are experts who have developed large experi-
nce with these operations, described the technical details of
ach, and carefully reported their results. These two reports
onstitute important contributions to the field of esophageal
urgery.
Lawrence H. Cohn, MD
Editor
